Beefing Up Computational Muscle to Understand Molecular Activity of Drug Candidates
Nadia Harhen, general manager of simulation and optimization for SandboxAQ, discusses the challenges of drug development it is seeking to address, how Sandbox AQ is leveraging quantum technologies, and why it is seeking to tackle an intractable set of diseases.